Evidence map›Paper›PMID 29104699›Full record

ReviewCancer nanotechnology2017

The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy.

Zahraa Youssef, Régis Vanderesse, Ludovic Colombeau, Francis Baros, Thibault Roques-Carmes, Céline Frochot, Habibah Wahab, Joumana Toufaily, Tayssir Hamieh, Samir Acherar and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Potential Biomedical Limitations of Graphene Nanomaterials.International journal of nanomedicine · 2023
    Review
  14. Article
  15. Spectroscopic Investigations of Porphyrin-TiOMolecules (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zahraa YoussefLaboratoire Réactions et Génie des Procédés, Université de Lorraine-CNRS, UMR 7274, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Régis VanderesseLaboratoire de Chimie Physique Macromoléculaire, Université de Lorraine-CNRS, UMR 7375, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Ludovic ColombeauLaboratoire Réactions et Génie des Procédés, Université de Lorraine-CNRS, UMR 7274, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Francis BarosLaboratoire Réactions et Génie des Procédés, Université de Lorraine-CNRS, UMR 7274, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Thibault Roques-CarmesLaboratoire Réactions et Génie des Procédés, Université de Lorraine-CNRS, UMR 7274, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Céline FrochotLaboratoire Réactions et Génie des Procédés, Université de Lorraine-CNRS, UMR 7274, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Habibah WahabSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia.
Joumana ToufailyLaboratory of Materials, Catalysis, Environment and Analytical Methods, Faculty of Sciences I, Lebanese University, Campus Rafic Hariri, Beyrouth, Lebanon.
Tayssir HamiehLaboratory of Materials, Catalysis, Environment and Analytical Methods, Faculty of Sciences I, Lebanese University, Campus Rafic Hariri, Beyrouth, Lebanon.
Samir AcherarLaboratoire de Chimie Physique Macromoléculaire, Université de Lorraine-CNRS, UMR 7375, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.
Amirah Mohd GazzaliLaboratoire de Chimie Physique Macromoléculaire, Université de Lorraine-CNRS, UMR 7375, 1 rue Grandville, BP 20451, 54001 Nancy Cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) have been shown to have good ability to improve the targeting and delivery of therapeutics. In the field of photodynamic therapy (PDT), this targeting advantage of NPs could help ensure drug delivery at specific sites. Among the commonly reported NPs for PDT applications, NPs from zinc oxide, titanium dioxide, and fullerene are commonly reported. In addition, graphene has also been reported to be used as NPs albeit being relatively new to this field. In this context, the present review is organized by these different NPs and contains numerous research works related to PDT applications. The effectiveness of these NPs for PDT is discussed in detail by collecting all essential information described in the literature. The information thus assembled could be useful in designing new NPs specific for PDT and/or PTT applications in the future.

Indexed as

FullereneGrapheneNanoparticlesPhotodynamic therapyTitanium dioxideZinc oxide

Identifiers

PMID29104699
PMCPMC5648744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.